Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 22.95
+0.30 (1.32%)
Sep 30, 2026, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 4.69 billion as of September 29, 2026. Its market cap has decreased by -39.54% in one year.
Market Cap
4.69B
Enterprise Value
5.55B
Revenue
815.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.95
ChartMarket Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 4.69B, an increase of 702.86%. That is a compound annual growth rate of 12.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.69B | -28.38% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.43B |
| TaiGen Biopharmaceuticals Holdings | 6.30B |
| Medigen Biotechnology | 5.26B |
| UnicoCell Biomed | 4.64B |
| Sinew Pharma | 4.28B |
| OBI Pharma | 4.27B |
| BRIM Biotechnology | 4.14B |
| Pharmosa Biopharm | 4.11B |